文献速递糖尿病

谁在入组?1型糖尿病TrialNet预防路径监测的参与差异

Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention.
PubMed 文献 · Diabetes Care · 2019-09-26

本研究分析TrialNet预防路径(PTP)研究的入组数据,考察筛查阳性后返回确认自身抗体及参加口服葡萄糖耐量试验(OGTT)监测的参与因素。结果显示年轻年龄与多次抗体阳性与更高参与几率相关,而少数族裔及父母身份与较低参与几率相关。

要点

  • 年轻年龄(<12岁 vs >18岁)与返回确认抗体(OR 2.12)及参加OGTT监测(OR 1.43)的几率增加相关。
  • 非白人非西班牙裔(OR 0.50)和西班牙裔(OR 0.69)受试者返回确认抗体的几率低于非西班牙裔白人。
  • 多次抗体阳性者参加OGTT监测的几率增加(OR 1.36),父母身份者参加监测的几率降低(OR 0.78)。

核心结论

  • 成功入组人群与失访人群存在明显差异,可用于制定提高持续参与的策略。

研究设计与样本

  • 研究采用多变量逻辑回归模型,分析TrialNet PTP研究中合格参与者在两个时间点的持续参与情况。
  • 第一个时间点为筛查后返回确认初始自身抗体阳性(Ab+)结果,第二个时间点为参加初始OGTT以入组监测方案。
  • 共纳入5,387名单一抗体阳性受试者分析返回确认,8,234名受试者中5,442名被确定合格入组PTP OGTT监测。

主要发现

  • 5,387名单一抗体阳性受试者中,4,204名(78%)返回确认抗体检测。
  • 8,234名受试者中,5,442名(66%)被确定合格入组PTP OGTT监测。
  • 年龄<12岁 vs >18岁返回确认抗体的OR为2.12(P<0.0001)。
  • 非白人非西班牙裔返回确认抗体的OR为0.50(P<0.0001),西班牙裔OR为0.69(P=0.0001),均相对于非西班牙裔白人。
  • 年龄<12岁 vs >18岁参加OGTT监测的OR为1.43(P<0.0001),多次抗体阳性OR为1.36(P<0.0001),父母身份OR为0.78(P=0.004)。

临床怎么用

  • 针对少数族裔和父母人群,可制定策略以提高其在1型糖尿病自然史和预防研究中的持续参与。
  • 年轻年龄和多次抗体阳性者参与度更高,可考虑作为重点招募对象。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To better understand potential facilitators of individual engagement in type 1 diabetes natural history and prevention studies through analysis of enrollment data in the TrialNet Pathway to Prevention (PTP) study. RESEARCH DESIGN AND METHODS: We used multivariable logistic regression models to examine continued engagement of eligible participants at two time points: 1) the return visit after screening to confirm an initial autoantibody-positive (Ab+) test result and 2) the initial oral glucose tolerance test (OGTT) for enrollment into the monitoring protocol. RESULTS: Of 5,387 subjects who screened positive for a single autoantibody (Ab), 4,204 (78%) returned for confirmatory Ab testing. Younger age was associated with increased odds of returning for Ab confirmation (age <12 years vs. >18 years: odds ratio [OR] 2.12, P < 0.0001). Racial and ethnic minorities were less likely to return for confirmation, particularly nonwhite non-Hispanic (OR 0.50, P < 0.0001) and Hispanic (OR 0.69, P = 0.0001) relative to non-Hispanic white subjects. Of 8,234 subjects, 5,442 (66%) were identified as eligible to be enrolled in PTP OGTT monitoring. Here, younger age and identification as multiple Ab+ were associated with increased odds of returning for OGTT monitoring (age <12 years vs. >18 years: OR 1.43, P < 0.0001; multiple Ab+: OR 1.36, P < 0.0001). Parents were less likely to enroll into monitoring than other relatives (OR 0.78, P = 0.004). Site-specific factors, including site volume and U.S. site versus international site, were also associated with differences in rates of return for Ab+ confirmation and enrollment into monitoring. CONCLUSIONS: These data confirm clear differences between successfully enrolled populations and those lost to follow-up, which can serve to identify strategies to increase ongoing participation.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sims EK, Geyer S, Johnson SB, et al. Who Is Enrolling? The Path to Monitoring in Type 1 Diabetes TrialNet's Pathway to Prevention. Diabetes Care. 2019. PMID: 31558546. doi:10.2337/dc19-0593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。